About Evidation
Evidation is a company based in Menlo Park (United States) founded in 2012 by Alessio Signorini. It operates as a Data-as-a-Service, and Professional Services. Evidation has raised $259.16 million across 7 funding rounds from investors including McKesson, General Electric and Revelation Partners. Evidation offers products and services including Real-World Data Platform and Patient Insights. Evidation operates in a competitive market with competitors including myTomorrows, Antidote, Dyania Health, SubjectWell and Belong, among others.
- Headquarter Menlo Park, United States
- Founders Alessio Signorini
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Evidation Health, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$259.16 M (USD)
in 7 rounds
-
Latest Funding Round
$153 M (USD), Series E
Mar 22, 2021
-
Investors
McKesson
& 13 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Evidation
Evidation offers a comprehensive portfolio of products and services, including Real-World Data Platform and Patient Insights. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Real-world health data is collected for research purposes.
Patient experiences are analyzed for health outcome improvements.
Unlock access to complete
Unlock access to complete
Funding Insights of Evidation
Evidation has successfully raised a total of $259.16M across 7 strategic funding rounds. The most recent funding activity was a Series E round of $153 million completed in March 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 7
- Last Round Series E — $153.0M
- First Round First Round
- Investors Count 14
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2021 | Amount | Series E - Evidation | Valuation | OMERS | |
| Jul, 2020 | Amount | Series D - Evidation | Valuation | B Capital | |
| Aug, 2018 | Amount | Series C - Evidation | Valuation | SV Health Investors , B Capital |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Evidation
Evidation has secured backing from 14 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include McKesson, General Electric and Revelation Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multistage investments are directed toward technology, healthcare, and climate sectors.
|
Founded Year | Domain | Location | |
|
Private equity investments are managed for municipal pension plans.
|
Founded Year | Domain | Location | |
|
Life sciences and tech focused impact VC firm funding companies in the US, the UK and Canada
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Evidation
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Evidation
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Evidation Comparisons
Competitors of Evidation
Evidation operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as myTomorrows, Antidote, Dyania Health, SubjectWell and Belong, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Platform provides access to drugs in development to patients and physicians
|
|
| domain | founded_year | HQ Location |
Provider of search engine tool for patients to explore, understand and access clinical trials.
|
|
| domain | founded_year | HQ Location |
Patients for clinical trials are identified through a dedicated platform.
|
|
| domain | founded_year | HQ Location |
Clinical trials marketplace for patient recruitment solutions is provided.
|
|
| domain | founded_year | HQ Location |
AI-enabled platform sources candidates for inclusive employment of disabled individuals.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Evidation
Frequently Asked Questions about Evidation
When was Evidation founded?
Evidation was founded in 2012.
Where is Evidation located?
Evidation is headquartered in Menlo Park, United States. It is registered at Menlo Park, California, United States.
Who is the current CEO of Evidation?
Leslie Oley Wilberforce is the current CEO of Evidation.
Is Evidation a funded company?
Evidation is a funded company, having raised a total of $259.16M across 7 funding rounds to date. The company's 1st funding round was a Series C of $30M, raised on Jan 01, 2012.
What does Evidation do?
Evidation is focused on collecting and analyzing real-world health data to support faster decisions in healthcare. Services are offered to life sciences, government, non-profit organizations, and digital health sectors. Solutions include patient cohort recontact, continuous data generation, and insights into patient experiences to improve access and outcomes. The platform integrates electronic health records, patient-reported outcomes, and social determinants of health for comprehensive research.
Who are the top competitors of Evidation?
Evidation's top competitors include myTomorrows, Dyania Health and SubjectWell.
What products or services does Evidation offer?
Evidation offers Real-World Data Platform and Patient Insights.
Who are Evidation's investors?
Evidation has 14 investors. Key investors include McKesson, General Electric, Revelation Partners, B Capital, and OMERS Private Equity.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.